Summary
Johnson & Johnson (JNJ) filed an 8-K on January 20, 2009, reporting its fourth quarter and full-year 2008 financial results. The filing primarily consists of a press release detailing sales and earnings for the quarter ended December 28, 2008. Investors should review this report to understand the company's recent financial performance, including revenue generation and profitability trends, in the context of the prevailing economic environment at the time. The key takeaway for investors is the announcement of the company's financial results. This includes specific figures for sales and earnings, which are crucial for assessing JNJ's operational efficiency, market position, and overall financial health. The supplementary sales data and condensed consolidated statement of earnings provide further detail for a more in-depth analysis of the company's performance during the fourth quarter of 2008.
Key Highlights
- 1Johnson & Johnson announced its fourth quarter and full-year 2008 financial results via an 8-K filing.
- 2The filing includes a press release dated January 20, 2009, detailing results for the quarter ended December 28, 2008.
- 3Key financial metrics such as sales and earnings for the fourth quarter are reported.
- 4Unaudited comparative supplementary sales data is provided for the fourth quarter.
- 5A condensed consolidated statement of earnings for the fourth quarter is included as an exhibit.
- 6The report serves as an official announcement of JNJ's financial performance for the specified period.